One stock that's been on my watch list for a while is CRISPR Therapeutics (NASDAQ: CRSP). The company has an intriguing ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that the U.S. Patent and Trademark Office ...

Is VRTX a good stock to buy? We came across a bullish thesis on Vertex Pharmaceuticals Incorporated on r/AIPortfolios by ...

Most people have never heard of α-Klotho. But the scientific community has been quietly obsessed with it since 1997, when ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $47.09, moving +1.42% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.54%. Meanwhile, the Dow ...

Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organisms Patent now opens up ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Even its conservative outlook shows very strong growth for the business this year.

Cathie Wood sold Circle shares worth $5.9 million over the weekend.

While interest in artificial intelligence (AI) continues to drive much of the action on the stock market, two medical ...